Alentis Raises $181m For Its ADCs Targeting Novel Target Claudin-1

 
• By Andrew McConaghie
  
Basel, Switzerland
Alentis is based in Basel, Switzerland. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Scrip